MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.510
-0.080 (-5.03%)
At close: Feb 27, 2026, 4:00 PM EST
1.530
+0.020 (1.32%)
After-hours: Feb 27, 2026, 7:24 PM EST
MetaVia Market Cap
MetaVia has a market cap or net worth of $4.84 million as of February 27, 2026. Its market cap has decreased by -67.50% in one year.
Market Cap
4.84M
Enterprise Value
-9.36M
1-Year Change
-67.50%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $4.84M, a decrease of -100.00%. That is a compound annual growth rate of -80.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 4.84M | -73.86% |
| Dec 31, 2025 | 18.54M | 5.97% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VivoSim Labs | 5.66M |
| Xenetic Biosciences | 5.50M |
| Silexion Therapeutics | 5.41M |
| Processa Pharmaceuticals | 5.03M |
| Bio Green Med Solution | 5.00M |
| Silo Pharma | 4.88M |
| Indaptus Therapeutics | 4.74M |
| Genprex | 4.71M |